Minnesota-based PetVivo is looking to list on the Nasdaq under the symbol "PETV." The company is currently listed over-the-counter under the same ticker symbol.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $1.92 |
|---|---|
| 52-week range | $1.20 - $5.14 |
| 50-day moving average | $2.30 |
| 200-day moving average | $2.13 |
| Wall St. target price | $7.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.44 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.92 from 2022-09-30
| 1 week (2022-09-26) | 0.79% |
|---|---|
| 1 month (2022-09-02) | -25.29% |
| 3 months (2022-07-01) | 5.49% |
| 6 months (2022-04-01) | -3.03% |
| 1 year (2021-10-01) | -28.89% |
|---|---|
| 2 years (2020-10-01) | 156.00% |
| 3 years (2019-10-03) | 331.46% |
| 5 years (2017-10-03) | 7.59% |
| Revenue TTM | $169,615 |
|---|---|
| Gross profit TTM | $-85,568 |
| Return on assets TTM | -121.92% |
| Return on equity TTM | -367.03% |
| Profit margin | 0% |
| Book value | $0.43 |
| Market capitalisation | $19.3 million |
TTM: trailing 12 months
We're not expecting PetVivo to pay a dividend over the next 12 months.
You may also wish to consider:
PetVivo's shares were split on a 1:4 basis on 30 December 2020. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PetVivo shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for PetVivo shares which in turn could have impacted PetVivo's share price.
Over the last 12 months, PetVivo's shares have ranged in value from as little as $1.2 up to $5.14. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetVivo's is 1.9277. This would suggest that PetVivo's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put PetVivo's beta into context you can compare it against those of similar companies.
PetVivo Holdings, Inc. , a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. .
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.